Incyte CEO on New Drugs, Jakafi Applications

Feb. 20 (Bloomberg) -- Herve Hoppenot, chief executive officer of Incyte Corp., talks with Bloomberg’s Meg Tirrell about the company's Jakfi drug used to treat a bone marrow disorder called myelofibrosis, Incyte's drug pipeline and the outlook for growth. Shares of the cancer-drug maker have tripled in the last year. (Source: Bloomberg)
Will Credit Suisse Rebound Post Dougan?
04:43 - Sparring Partners Managing Partner Bernhard Bauhofer discusses Credit Suisse’s earnings and outlook for the company. He speaks with Jonathan Ferro on Bloomberg Television’s “On The Move.” (Source: Bloomberg)
  • Germany's Schaeuble on Greek Crisis, Ukraine, Euro Zone
  • ARM Holdings Stock Rises on Earnings Beat
  • Factors That May Cause Earnings Confusion